Discovery of ganoderic acid A (GAA) PROTACs as MDM2 protein degraders for the treatment of breast cancer

化学 癌症 乳腺癌 计算生物学 癌症研究 遗传学 生物
作者
Yan Li,Guangyu Li,Chenwei Zuo,Xiaolin Wang,Fang Han,Yi Jia,Hai Shang,Yu Tian
出处
期刊:European journal of medicinal chemistry [Elsevier BV]
卷期号:270: 116367-116367 被引量:21
标识
DOI:10.1016/j.ejmech.2024.116367
摘要

Breast cancer is one of the most common female malignant tumors, with triple-negative breast cancer (TNBC) being the most specific, highly invasive, metastatic and associated with a poor prognosis. Our previous study showed that the natural product ganoderic acid A (GAA) has a certain affinity for MDM2. In this study, two series of novel GAA PROTACs C1–C10 and V1–V10 were designed and synthesized for the treatment of breast cancer. The antitumor activity of these compounds was evaluated against four human tumor cell lines (MCF-7, MDA-MB-231, SJSA-1, and HepG2). Among them, V9 and V10 showed stronger anti-proliferative effects against breast cancer cells, and V10 showed the best selectivity in MDA-MB-231 cells (TNBC), which was 5-fold higher than that of the lead compound GAA. Preliminary structure-activity analysis revealed that V-series GAA PROTACs had better effects than C-series, and the introduction of 2O–4O PEG linkers could significantly improve the antitumor activity. Molecular docking, surface plasmon resonance (SPR), cellular thermal shift assay (CETSA), and Western blot researches showed that both V9 and V10 could bind with MDM2, and degrade the protein through the ubiquitin-proteasome system. Molecular dynamics simulation (MD) revealed that V10 is a bifunctional molecule that can bind to von Hippel-Lindau (VHL) at one end and target MDM2 at the other. In addition, V10 promoted the upregulation of p21 in p53-mutant MDA-MB-231 cells, and induced apoptosis via down-regulation of the bcl-2/bax ratio and the expression of cyclin B1. Finally, in vivo experiments showed that, V10 also exhibited good tumor inhibitory activity in xenografted TNBC zebrafish models, with an inhibition rate of 27.2% at 50 μg/mL. In conclusion, our results suggested that V10 has anti-tumor effects on p53-mutant breast cancer in vitro and in vivo, and may be used as a novel lead compound for the future development of TNBC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zzyy完成签到,获得积分10
刚刚
Akim的应助被Zx采纳,获得10
1秒前
木头发布了新的文献求助10
1秒前
CodeCraft的应助被木夫贝采纳,获得10
1秒前
香蕉觅云的应助被阿冲采纳,获得10
1秒前
2秒前
失眠小懒虫完成签到,获得积分10
2秒前
打打的应助被shiv采纳,获得50
2秒前
3秒前
XPR发布了新的文献求助10
3秒前
3秒前
希望天下0贩的0的应助被精一采纳,获得10
4秒前
yize完成签到,获得积分10
6秒前
所所的应助被体贴的小馒头采纳,获得10
7秒前
刘亦然完成签到 ,获得积分10
7秒前
小马甲的应助被明前易拉罐采纳,获得10
7秒前
8秒前
川一发布了新的文献求助10
8秒前
我是老大的应助被coco采纳,获得10
9秒前
可爱的函函的应助被yize采纳,获得10
10秒前
科勒的黑猩猩完成签到 ,获得积分10
11秒前
所所的应助被栗子砸采纳,获得10
11秒前
efficient发布了新的文献求助10
12秒前
12秒前
xiaobuding完成签到,获得积分10
13秒前
丘比特的应助被路小雨采纳,获得10
13秒前
14秒前
云起完成签到 ,获得积分10
14秒前
耍酷巨人完成签到,获得积分10
14秒前
15秒前
诚心面包发布了新的文献求助10
16秒前
16秒前
哈哈哈发布了新的文献求助20
16秒前
17秒前
17秒前
17秒前
wwwwwwww完成签到,获得积分10
18秒前
benlaron发布了新的文献求助10
18秒前
iltaf7869发布了新的文献求助10
19秒前
科研小白发布了新的文献求助10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181839
求助须知:如何正确求助?哪些是违规求助? 9571537
关于积分的说明 21818552
捐赠科研通 7778091
什么是DOI,文献DOI怎么找? 3433524
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479621